商品代碼 | 市值 | 價格 | 漲跌 % | 成交量 | 相對成交量 | P/E | 攤薄每股收益 TTM | 每股收益緩慢成長 TTM年增率 | 股息殖利率 % TTM | 分析師評級 |
---|---|---|---|---|---|---|---|---|---|---|
BMKBENCHMARK HLDGS PLC | 2.95 B NOK | 3.98 NOK | −0.50% | 105.56 K | 1.37 | — | −0.60 NOK | −66.47% | 0.00% | 強力買入 |
MEDIMEDISTIM ASA | 2.78 B NOK | 150.5 NOK | −1.31% | 1.07 K | 0.11 | 27.12 | 5.55 NOK | −13.40% | 2.95% | 中立 |
PHOPHOTOCURE ASA | 1.54 B NOK | 56.4 NOK | −0.53% | 38.35 K | 0.53 | 113.64 | 0.50 NOK | — | 0.00% | 強力買入 |
VISTNVISTIN PHARMA ASA | 1.02 B NOK | 23.0 NOK | −0.43% | 2.55 K | 0.38 | 16.61 | 1.39 NOK | +37.91% | 4.33% | — |
NYKDNYKODE THERAPEUTICS ASA | 856.2 M NOK | 2.622 NOK | 0.00% | 858.04 K | 0.40 | — | −1.22 NOK | +17.44% | 0.00% | 買入 |
AZTARCTICZYMES TECHNOLOGIES ASA | 705.81 M NOK | 13.72 NOK | −0.72% | 29.82 K | 0.55 | 110.73 | 0.12 NOK | −64.58% | 0.00% | 買入 |
GGENTGENTIAN DIAGNOSTICS ASA | 586.05 M NOK | 39.4 NOK | +3.68% | 6.63 K | 6.68 | 271.35 | 0.15 NOK | — | 0.00% | 強力買入 |
LYTIXLYTIX BIOPHARMA AS | 389.87 M NOK | 5.66 NOK | −1.05% | 42.69 K | 0.44 | — | −1.85 NOK | +24.63% | 0.00% | — |
BGBIOBERGENBIO ASA | 347.72 M NOK | 8.785 NOK | −1.25% | 156.43 K | 0.50 | — | −4.91 NOK | +85.91% | 0.00% | 強力買入 |
EEXTXEXACT THERAPEUTICS AS | 211.3 M NOK | 3.20 NOK | −4.19% | 70 | 0.00 | — | −1.71 NOK | −42.45% | 0.00% | — |
LIFELIFECARE ASA | 183.89 M NOK | 15.45 NOK | +33.19% | 319.62 K | 8.69 | — | −15.43 NOK | −634.96% | 0.00% | — |
ULTIULTIMOVACS ASA | 71.39 M NOK | 2.120 NOK | +2.17% | 380.48 K | 0.91 | — | −4.34 NOK | +26.84% | 0.00% | 中立 |
AABSARCTIC BIOSCIENCE AS | 57.84 M NOK | 2.98 NOK | +30.70% | 570.61 K | 7.01 | — | −1.91 NOK | −19.37% | 0.00% | 中立 |
CCRNACIRCIO HOLDING ASA | 56.53 M NOK | 0.710 NOK | −2.20% | 711.96 K | 0.86 | 0.83 | 0.86 NOK | — | 0.00% | 中立 |
PCIBPCI BIOTECH HOLDING ASA | 48.08 M NOK | 1.240 NOK | −3.73% | 50.67 K | 0.57 | — | — | — | 0.00% | — |
NTGNORDIC TECHNOLOGY GROUP AS | — | 1.92 NOK | −8.57% | 20.68 K | 0.06 | — | −2.33 NOK | −21.65% | 0.00% | — |
OONCINONCOINVENT ASA | — | 3.00 NOK | −3.23% | 47.29 K | 0.83 | — | — | — | — | — |